A different type of acute myocarditis: a case report of acute autoimmune myocarditis mediated by anti-PD-1 T lymphocyte receptor (pembrolizumab)

BACKGROUND : Pembrolizumab is an immune check-point inhibitor (ICI), which acts by blocking the T lymphocyte PD-1 inhibitor receptor. It has been increasingly used in advanced or non-responsive tumours with promising results. However, acute myocarditis is an infrequent but potentially life-threateni...

Descripción completa

Detalles Bibliográficos
Autores principales: Salido Iniesta, Mario, López López, Laura, Carreras Costa, Francesc, Sionis, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649507/
https://www.ncbi.nlm.nih.gov/pubmed/33204987
http://dx.doi.org/10.1093/ehjcr/ytaa214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649507/
https://www.ncbi.nlm.nih.gov/pubmed/33204987
http://dx.doi.org/10.1093/ehjcr/ytaa214

Ejemplares similares